[ad_1] Pfizer Inc.’s stock tumbled 4% premarket Friday, after the company said it would not…
Biotechnology
-
-
STOCK MARKET
Avidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone payments
by userby user[ad_1] Avidity Biosciences Inc. said Tuesday it’s expanding its cardiovascular collaboration with Bristol Myers Squibb…
-
STOCK MARKET
Undaunted by hurricanes, COVID and quakes, Puerto Rico ready for its tech moment
by userby user[ad_1] Hurricanes, a pandemic and an earthquake can’t stop a swelling tech movement in Puerto…
-
STOCK MARKET
IPO pipeline welcomes some profitable companies, raising hopes for a rebound
by userby user[ad_1] The U.S. initial public offering calendar is empty this holiday-shortened week, but some recent…
-
[ad_1] Wuxi XDC Cayman’s shares rose in their trading debut in Hong Kong as investors…
-
STOCK MARKET
BioNTech’s stock rallies after it posts surprise Q3 profit and revenue that tops estimates
by userby user[ad_1] BioNTech SE’s stock rose 2.5% early Monday after the company posted a surprise profit…
-
STOCK MARKET
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
by userby user[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for…
-
STOCK MARKET
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
by userby user[ad_1] Amgen Inc.’s stock fell 3.3% Tuesday to put it on track for its biggest…
-
[ad_1] The Nasdaq Composite Index is in the midst of a correction. A close look…
-
STOCK MARKET
Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable
by userby user[ad_1] Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering…